|
Observatoire européen des drogues et des toxicomanies. (2001). Rapport annuel sur l'état du phénomène de la drogue dans l'Union européenne – 2001. Rapport annuel. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; communicable disease; AODR mortality; Europe; annual report
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2001). Annual report on the state of the drugs problem in the European Union 2001. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; communicable disease; AODR mortality; Europe; annual report
|
|
|
Europäische Beobachtungsstelle für Drogen und Drogensucht. (2001). Jahresbericht über den Stand der Drogenpolitik in der Europäischen Union 2001. Jahresbericht. Luxemburg: Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; communicable disease; AODR mortality; Europe; annual report
|
|
|
Rhodes, T., Barnard, M., Fountain, J., Hariga, F., Avilés, N. R., Vicente, J., et al. (2001). Injecting drug use, risk behaviour and qualitative research in the time of AIDS (T. Rhodes, G. Greenwood, & K. Robertson, Eds.). Insights, 4. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Injecting is one of the main causes of health damage related to illegal drug use today. It is strongly related to fatal and non-fatal overdoses, as well as to the transmission of infectious diseases, such as hepatitis B and C, and HIV infection. Yet studying drug injection is no easy task, due to its hidden nature and low prevalence in general population terms. It is necessary to understand why and how people decide to engage in such dangerous behaviour, and to analyse how drug injectors perceive risk. There are fundamental issues that need to be understood in order to interpret and better use epidemiological quantitative data on the subject. This publication is the result of a review undertaken by the EMCDDA working group on injecting drug use and risk behaviour. It helps in understanding injecting drug use and its adverse health consequences, particularly risk behaviour associated with the transmission of HIV.
Keywords: AOD use, abuse, and dependence; chemical addiction; intravenous drug user; AOD induced risk; AODR mortality; infection; HIV infection; Aids; hepatitis B; hepatitis C; Europe; European Union
|
|
|
various. (2000). Reviewing current practice in drug-substitution treatment in the European Union (M. Farrell, S. Howes, A. Verster, M. Davoli, U. Solberg, G. Greenwood, et al., Eds.). Insights, 3. Luxembourg: Office for Official Publications of the European Communities.
Abstract: This volume is the result of an EMCDDA-commissioned study carried out in 1998 and 1999 into one of the most widely discussed drug-related topics in Europe today: substitution treatment. The study was prompted by the lively debate on the issue in the mid-1990s, when Switzerland launched its first heroin trial, France began buprenorphine treatment and methadone programmes expanded rapidly throughout Europe. These initiatives led to an increased focus on substitution treatment and to the trajectories it was to follow in the future. The volume opens with a historical overview of substitution treatment, the development of methadone maintenance and other substitution services and a section on monitoring and evaluation. It closes with a series of country profiles for each of the then 15 EU Member States, all containing an introduction to substitution treatment in the country concerned.
Keywords: treatment and maintenance; drug substitution therapy; methadone maintenance; buprenorphine maintenance; heroin-assisted treatment; Switzerland; Europe; European Union
|
|
|
Osservatorio europeo delle droghe e delle tossicodipendenze. (2000). Relazione annuale sull'evoluzione del fenomeno della droga nell'Unione europea – 2000. Relazione annuale. Lussemburgo: Ufficio delle pubblicazioni ufficiali delle Comunità europee.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; communicable disease; AODR mortality; Europe; annual report
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2000). Annual report on the state of the drugs problem in the European Union – 2000. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: government and politics; AOD use, abuse, and dependence; AOD public policy strategy; treatment and maintenance; harm reduction; prevention; law enforcement; AODR mortality; communicable disease; drug market; quality control; drug substitution therapy; gender; woman; pregnancy; parent; statistical data; Europe
|
|
|
Europäische Beobachtungsstelle für Drogen und Drogensucht. (2000). Jahresbericht über den Stand der Drogenpolitik in der Europäischen Union – 2000. Jahresbericht. Luxemburg: Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; communicable disease; AODR mortality; Europe; annual report
|
|
|
Observatoire européen des drogues et des toxicomanies. (2000). Rapport annuel sur l'état du phénomène de la drogue dans l'Union européenne – 2000. Rapport annuel. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; communicable disease; AODR mortality; Europe; annual report
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (1999). 1999 Extended annual report on the state of the drugs problem in the European Union. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: government and politics; international area; amphetamines; annual report; AOD effects and AODR problems; AOD public policy strategy; AOD use, abuse, and dependence; AODR mortality; cannabis; cocaine; communicable disease; crack cocaine; ecstasy; Europe; illicit drug sales; intravenous injection; prison; law enforcement; LSD; MDMA; opioids in any form; other drug laws; piperazine; prevalence; prevention; public policy on illicit drugs; research; treatment and maintenance
|
|